{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T08:05:17Z","timestamp":1782633917567,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00417-022-05701-x","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T07:02:53Z","timestamp":1653548573000},"page":"3357-3363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo"],"prefix":"10.1007","volume":"260","author":[{"given":"Katsuya","family":"Nagahori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Keino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isami","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle A.","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"5701_CR1","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","volume":"336","author":"LS Newman","year":"1997","unstructured":"Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224\u20131234. https:\/\/doi.org\/10.1056\/NEJM199704243361706","journal-title":"N Engl J Med"},{"key":"5701_CR2","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153\u20132165. https:\/\/doi.org\/10.1056\/NEJMra071714","journal-title":"N Engl J Med"},{"key":"5701_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1164\/arrd.1984.130.1.29","volume":"130","author":"G Hillerdal","year":"1984","unstructured":"Hillerdal G, Nou E, Osterman K et al (1984) Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 130:29\u201332. https:\/\/doi.org\/10.1164\/arrd.1984.130.1.29","journal-title":"Am Rev Respir Dis"},{"key":"5701_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","volume":"145","author":"BA Rybicki","year":"1997","unstructured":"Rybicki BA, Major M, Popovich J et al (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145:234\u2013241. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009096","journal-title":"Am J Epidemiol"},{"key":"5701_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/bjo.84.1.110","volume":"84","author":"A Rothova","year":"2000","unstructured":"Rothova A (2000) Ocular involvement in sarcoidosis. Br J Ophthalmol 84:110\u2013116. https:\/\/doi.org\/10.1136\/bjo.84.1.110","journal-title":"Br J Ophthalmol"},{"key":"5701_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3109\/09273948.2013.855796","volume":"22","author":"K Nagata","year":"2014","unstructured":"Nagata K, Maruyama K, Sugita S et al (2014) Age differences in sarcoidosis patients with posterior ocular lesions. Ocul Immunol Inflamm 22:257\u2013262. https:\/\/doi.org\/10.3109\/09273948.2013.855796","journal-title":"Ocul Immunol Inflamm"},{"key":"5701_CR7","doi-asserted-by":"publisher","first-page":"e0202585","DOI":"10.1371\/journal.pone.0202585","volume":"13","author":"K Takayama","year":"2018","unstructured":"Takayama K, Harimoto K, Sato T et al (2018) Age-related differences in the clinical features of ocular sarcoidosis. PLoS ONE 13:e0202585. https:\/\/doi.org\/10.1371\/journal.pone.0202585","journal-title":"PLoS ONE"},{"key":"5701_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1183\/09031936.00075307","volume":"31","author":"T Morimoto","year":"2008","unstructured":"Morimoto T, Azuma A, Abe S et al (2008) Epidemiology of sarcoidosis in Japan. Eur Respir J 31:372\u2013379. https:\/\/doi.org\/10.1183\/09031936.00075307","journal-title":"Eur Respir J"},{"key":"5701_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/09273940902818861","volume":"17","author":"CP Herbort","year":"2009","unstructured":"Herbort CP, Rao NA, Mochizuki M (2009) International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm 17:160\u2013169. https:\/\/doi.org\/10.1080\/09273940902818861","journal-title":"Ocul Immunol Inflamm"},{"key":"5701_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ophtha.2017.07.006","volume":"125","author":"NR Acharya","year":"2018","unstructured":"Acharya NR, Browne EN, Rao N et al (2018) Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients. Ophthalmology 125:119\u2013126. https:\/\/doi.org\/10.1016\/j.ophtha.2017.07.006","journal-title":"Ophthalmology"},{"key":"5701_CR11","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki M, Smith JR, Takase H et al (2019) Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol 103:1418\u20131422. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313356","journal-title":"Br J Ophthalmol"},{"key":"5701_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1046\/j.1442-9071.2003.00666.x","volume":"31","author":"A Lobo","year":"2003","unstructured":"Lobo A, Barton K, Minassian D et al (2003) Visual loss in sarcoid-related uveitis. Clin Exp Ophthalmol 31:310\u2013316. https:\/\/doi.org\/10.1046\/j.1442-9071.2003.00666.x","journal-title":"Clin Exp Ophthalmol"},{"key":"5701_CR13","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/bjophthalmol-2016-309767","volume":"101","author":"C Rochepeau","year":"2017","unstructured":"Rochepeau C, Jamilloux Y, Kerever S et al (2017) Long-term visual and systemic prognoses of 83 cases of biopsy-proven sarcoid uveitis. Br J Ophthalmol 101:856\u2013861. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309767","journal-title":"Br J Ophthalmol"},{"key":"5701_CR14","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/s0161-6420(96)30417-x","volume":"103","author":"MR Dana","year":"1996","unstructured":"Dana MR, Merayo-Lloves J, Schaumberg DA et al (1996) Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology 103:1846\u20131853. https:\/\/doi.org\/10.1016\/s0161-6420(96)30417-x","journal-title":"Ophthalmology"},{"key":"5701_CR15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","journal-title":"Am J Ophthalmol"},{"key":"5701_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s10384-020-00809-1","volume":"65","author":"KH Sonoda","year":"2021","unstructured":"Sonoda KH, Hasegawa E, Namba K et al (2021) Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol 65:184\u2013190. https:\/\/doi.org\/10.1007\/s10384-020-00809-1","journal-title":"Jpn J Ophthalmol"},{"key":"5701_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1758159","author":"M Handa-Miyauchi","year":"2020","unstructured":"Handa-Miyauchi M, Takase H, Tanaka Akiyama M et al (2020) A validation study of the revised diagnostic criteria from the International Workshop on Ocular Sarcoidosis at a single institute in Japan. Ocul Immunol Inflamm. https:\/\/doi.org\/10.1080\/09273948.2020.1758159","journal-title":"Ocul Immunol Inflamm"},{"key":"5701_CR18","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885\u20131889. https:\/\/doi.org\/10.1164\/ajrccm.164.10.2104046","journal-title":"Am J Respir Crit Care Med"},{"key":"5701_CR19","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/thx.2006.062836","volume":"61","author":"J Gribbin","year":"2006","unstructured":"Gribbin J, Hubbard RB, Le Jeune I et al (2006) Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 61:980\u2013985. https:\/\/doi.org\/10.1136\/thx.2006.062836","journal-title":"Thorax"},{"key":"5701_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1442-9071.2009.02102.x","volume":"37","author":"H Keino","year":"2009","unstructured":"Keino H, Nakashima C, Watanabe T et al (2009) Frequency and clinical features of intraocular inflammation in Tokyo. Clin Exp Ophthalmol 37:595\u2013601. https:\/\/doi.org\/10.1111\/j.1442-9071.2009.02102.x","journal-title":"Clin Exp Ophthalmol"},{"key":"5701_CR21","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1183\/09031936.95.08020272","volume":"8","author":"M Shirai","year":"1995","unstructured":"Shirai M, Sato A, Chida K (1995) The influence of ovarian hormones on the granulomatous inflammatory process in the rat lung. Eur Respir J 8:272\u2013277. https:\/\/doi.org\/10.1183\/09031936.95.08020272","journal-title":"Eur Respir J"},{"key":"5701_CR22","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1159\/000324295","volume":"81","author":"K Tajima","year":"2011","unstructured":"Tajima K, Miura K, Ishiwata T et al (2011) Sex hormones alter Th1 responses and enhance granuloma formation in the lung. Respiration 81:491\u2013498. https:\/\/doi.org\/10.1159\/000324295","journal-title":"Respiration"},{"key":"5701_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/aje\/kws145","volume":"176","author":"YC Cozier","year":"2012","unstructured":"Cozier YC, Berman JS, Palmer JR et al (2012) Reproductive and hormonal factors in relation to incidence of sarcoidosis in US Black women: The Black Women\u2019s Health Study. Am J Epidemiol 176:635\u2013641. https:\/\/doi.org\/10.1093\/aje\/kws145","journal-title":"Am J Epidemiol"},{"key":"5701_CR24","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","volume":"13","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux Y, Kodjikian L, Broussolle C et al (2014) Sarcoidosis and uveitis. Autoimmun Rev 13:840\u2013849. https:\/\/doi.org\/10.1016\/j.autrev.2014.04.001","journal-title":"Autoimmun Rev"},{"key":"5701_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-1-4757-9182-2_67","volume":"336","author":"CA Stegeman","year":"1993","unstructured":"Stegeman CA, Tervaert JW, Huitema MG et al (1993) Serum markers of T-cell activation in relapses of Wegener\u2019s granulomatosis. Adv Exp Med Biol 336:389\u2013392. https:\/\/doi.org\/10.1007\/978-1-4757-9182-2_67","journal-title":"Adv Exp Med Biol"},{"key":"5701_CR26","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2017.4771","volume":"135","author":"F Groen-Hakan","year":"2017","unstructured":"Groen-Hakan F, Eurelings L, ten Berge JC et al (2017) Diagnostic value of serum-soluble interleukin 2 receptor levels vs angiotensin-converting enzyme in patients with sarcoidosis-associated uveitis. JAMA Ophthalmol 135:1352\u20131358. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4771","journal-title":"JAMA Ophthalmol"},{"key":"5701_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7878\/jjsogd.35.3","volume":"35","author":"N Shijubo","year":"2015","unstructured":"Shijubo N, Yamaguchi T (2015) Diagnosis criteria and classification of disease severity for sarcoidosis in Japan. Japanese J Sarcoidosis Other Granulomatous Disorders 35:3\u20138. https:\/\/doi.org\/10.7878\/jjsogd.35.3","journal-title":"Japanese J Sarcoidosis Other Granulomatous Disorders"},{"issue":"123","key":"5701_CR28","first-page":"156","volume":"2019","author":"R Matsushima","year":"2019","unstructured":"Matsushima R, Usui Y, Umazume A et al (2019) Significance of serum-soluble interleukin-2 receptor level on the diagnosis of uveitis. J Jpn Ophthalmol Soc 2019(123):156\u2013160","journal-title":"J Jpn Ophthalmol Soc"},{"key":"5701_CR29","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1136\/bjophthalmol-2020-317354","volume":"105","author":"H Takase","year":"2021","unstructured":"Takase H, Acharya NR, Babu K et al (2021) Recommendations for the management of ocular sarcoidosis from the International Workshop on Ocular Sarcoidosis. Br J Ophthalmol 105:1515\u20131519. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317354","journal-title":"Br J Ophthalmol"},{"key":"5701_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/bjo.87.8.968","volume":"87","author":"AA Okada","year":"2003","unstructured":"Okada AA, Wakabayashi T, Morimura Y et al (2003) Trans-Tenon\u2019s retrobulbar triamcinolone infusion for the treatment of uveitis. Br J Ophthalmol 87:968\u2013971. https:\/\/doi.org\/10.1136\/bjo.87.8.968","journal-title":"Br J Ophthalmol"},{"key":"5701_CR31","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.ophtha.2015.06.042","volume":"122","author":"JH Kempen","year":"2015","unstructured":"Kempen JH, Altaweel MM, Drye LT et al (2015) Benefits of systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular implant for intermediate uveitis, posterior uveitis, and panuveitis: fifty-four-month results of the Multicenter Uveitis Steroid Treatment (MUST) trial and follow-up study. Ophthalmology 122:1967\u20131975. https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.042","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05701-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T05:06:51Z","timestamp":1663218411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05701-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["5701"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05701-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Kyorin University Hospital Research Ethics Committee and with the tenets of the Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"HK: research funds from Mitsubishi Tanabe Pharma (Japan), lecture fees from Nikon (Japan), Kowa (Japan), Novartis Pharma (Japan), Mitsubishi Tanabe Pharma (Japan), Carl Zeiss Meditec (Germany), Santen Pharmaceutical (Japan), Bayer (Japan) and Senju Pharmaceutical (Japan). AAO: research funds from Bayer (Japan) and Alcon (Japan); consultant fees from Bayer (Japan and Germany), Chugai Pharmaceutical (Japan), Novartis (Japan and Switzerland), Hoya (Japan), Daiichi Sankyo (Japan), Astellas (Japan); lecture fees from Novartis (Japan), Bayer (Japan and Australia), Pfizer (Japan), Santen (Japan), Mitsubishi Tanabe Pharma (Japan), Allergan (Japan), Senju (Japan), Abbvie (Japan), Otsuka Pharmaceutical (Japan).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was a retrospective chart review and a waiver of informed consent was approved by the Ethics Committee. Patients were given the opportunity to \u201copt out.\u201d","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}